Sections
You are here: Home › Attendance to the 4th Annual DIA Clinical Forum - October 11-13, 2010
 

Attendance to the 4th Annual DIA Clinical Forum - October 11-13, 2010

Cardinal Systems centralized service package dedicated to international phase II and III will be largely represented during the 4th Clinical Formum in October 11-13th in Lisbon

 

Cardinal Systems has reinforced its IxRS, EDC and Medical Imaging forces in order to better respond to pharmaceutical industry companies’ constraints in term of volume and flexibility for their International clinical trials.

 

Cardinal Systems Project managers have an essential role in understanding the methodology under logistical complexity and therefore better anticipate appropriate solutions.

 

Cardinal Systems has dedicated its offer to international phase II/III clinical trial management including innovative study design and regulatory methodological approach.

 

Thanks to its broad range of centralised services such as IxRS, EDC and Medical Imaging, Cardinal Systems can streamline operational processes and workflows and optimise budget & timelines.

 

Year after year, Cardinal Systems has developed reliable links with its clients in order to successfully manage clinical programs and reach patient recruitment objectives in line with appropriate methodology. This strategic partnership includes Risk assessment, Regulatory advice and Budget estimate delivery.

 

To meet with our business and operational representatives during the event, please send an email with your contact details to businessdev@cardinal-sys.com.

 

 

To know more about this event, please refer to DIA official website:

http://www.diahome.org/DIAHOME/FlagshipMeetings/Home.aspx?meetingid=22350

 

 

Document Actions
Partners & Working Groups

Cardinal Systems works in partnership with O4CP for the Loulla & Philla FP7 project.

Loulla Philla

 

Cardinal Systems participates actively in working groups, such as DIA, PSI, CDISC, SFdS and EFSPI.

 

Cardinal Systems has been supporting France Biotech since 2001, and works closely with governmental institutions implicated in the valorisation of innovation, such as Oseo, Pactepme and Medicen.

France Biotech

Partners